Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India
[243 Pages Report] The global Venous Thromboembolism Treatment Market is expected to exceed US$ 1.53 Billion by 2022. Growing acceptance of novel venous thromboembolism treatment devices in emerging economies such as India, China, Brazil, and Russia among others is estimated to facilitate the growth in the market.
Attribute | Details |
---|---|
Venous Thromboembolism Treatment Market Estimated Size in 2022 | US$ 1.53 Billion |
Venous Thromboembolism Treatment Market Projected Size in 2029 | US$ 1.91 Billion |
Venous Thromboembolism Treatment Market Historical CAGR (2014 to 2021) | 3.7% |
Venous Thromboembolism Treatment Market Value-based CAGR (2022 to 2029) | 3.7% |
Future Market Insights (FMI) states that the demand in the global venous thromboembolism treatment market is projected to surge at 3.7% CAGR during the forecast period 2022 to 2029.
The deep venous thrombosis segment is anticipated to account for more than 3/5th of venous thromboembolism treatment sales by 2022, reveals FMI. Also, percutaneous thrombectomy devices and catheter-directed thrombolysis devices are estimated to collectively account for over half of the demand share through 2029.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 3.97% |
H1, 2022 Projected | 3.65% |
H1, 2022 Outlook | 3.15% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 50 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (-) 82 ↓ |
The comparative analysis and market growth rate of global venous thromboembolism treatment market as studied by Future Market Insights, will show a negative BPS growth in H1-2022 outlook as compared to H1-2022 projected period by 50 BPS. A decline in the BPS growth is expected in H1-2022 as well, over H1- 2021 duration with 82 Basis Point Share (BPS).
According to FMI analysis, the decline in BPS values is attributed to the treatment inefficiency for acute coronary event, and the resultant decrease in the positive treatment outcomes associated with venous thromboembolism treatment.
Moreover, for patients with increased length of hospital stay, the treatment option is ineffective, and results in poor patient compliance. This is a major cause for the resultant decline in the BPS.
Additionally, the market is subject to macroeconomic and industry dynamics which include regulatory requirements for drugs and therapeutics, device licensing and distribution, and treatment compliance.
The key developments in the market include the induction of direct oral anticoagulants, which may promote the growth and propulsion of the market during the forecasted years.
Sales in the global venous thromboembolism treatment market totaled US$ 1.46 Bn in 2021, as per FMI. The market is estimated to expand by 1.5x over the forecast period 2022-2029
Venous thromboembolism is a condition in which blood clots are formed in deep veins of arms, groin, or legs and travels with the blood circulation, lodging in the lungs. It can restrict the flow of blood and oxygen damaging the body’s tissues and organs. Hence, growing awareness regarding the severity of the diseases across developing economies is favoring the growth in the market.
Rising prevalence of pulmonary embolism disease is one of the leading factors favoring the growth in the market. For instance, according to the Centers for Disease Control and Prevention, around 900,000 people in the U.S. are affected by pulmonary embolism, causing around 60,000 to 100,000 deaths every year.
As several patients are at high risk of developing more serious venous thromboembolism, therapeutics such as retrievable vena cava filters are increasingly being used to stop the progression of malignant pulmonary embolism. This is expected to augment the sales of venous thromboembolism treatments in the market.
A substantial rise in surgical procedures conducted worldwide is registered over the last few years. This can be attributable to the rising burden of various chronic ailments around the world. Moreover, higher demand for cosmetics surgeries also will create opportunities for growth of the market.
According to a report by the American Society of Plastic Surgeons, around 15.6 million cosmetic procedures and 6.8 million reconstructive procedures were reported to be conducted across the U.S. in 2020. As surgical procedures increase the risk of blood clots in the body causing pulmonary embolism, this rise in surgeries is expected to create high demand for the prevention and therapeutics of the disease, creating growth opportunities in the market.
In addition, increasing number of research and development (R&D) activities for the development of novel devices, filters, and therapeutics across countries such as the U.S., China, the U.K., and India are favoring the growth in the market. On account of this, the global venous thromboembolism treatment market is poised to total US$ 1.91 Bn through 2029, expanding at 3.7% CAGR during the forecast period.
“Favorable Reimbursement Policies Favoring Demand for Thromboembolic Therapy in the U.S.”
As per Future Market Insights (FMI), the U.S. is estimated to emerge as one of the largest revenue-generating markets for venous thromboembolism treatment.
Presence of favorable reimbursement policies facilitating treatment of various diseases, covering procedures such as chemotherapy and thromboembolic therapy in the U.S. is favoring the growth in the market. In addition, the country also offers high incentives to doctors and physicians to use filters for prophylactic treatments. These factors are estimated to accelerate the sales of venous thromboembolism treatments in the U.S.
“Growing Retrieval Rate of Vena Cava Filters to Push Demand for Venous Thromboembolism Management”
FMI states that the U.K. is anticipated to account for a significant share in the Europe venous thromboembolism treatment market over the assessment period.
Vena cava filters can cause serious medical complications post-surgical implantation. Hence, these filters have to be removed once the risk of pulmonary embolism declines.
With rising instance of vena cava filters being left inside patients, the demand for venous thromboembolism management rapidly increasing. Thus, market players in the country are aiming at developing advanced tracking systems for patients follow-up to ensure the removal of these filters. Such developments in the country are facilitating the growth in the market.
“Increasing Burden of Lifestyle Diseases Fueling the Venous Thromboembolism Treatment Device Sales”
The China venous thromboembolism treatment market is projected to register growth at a rapid CAGR between 2022 and 2029, as per FMI.
Growing prevalence of lifestyle disorders such as diabetes, obesity, low blood pressure, and others are significantly increasing the burden of pulmonary embolism as these disorders increase the risk of blood clots.
As venous thromboembolism treatment devices such as thrombectomy devices and blood clot retrieval devices assist in dissolving the blood clots at initials stages. Consequently the rising demand for these devices is favoring the growth in the country.
“Rising Inclination towards Minimally Invasive Treatment Augmenting the Demand Venous Thromboembolism Management Devices”
Future Market Insights forecasts catheter-directed thrombolysis devices to account for maximum venous thromboembolism treatment sales through 2029.
Catheter-directed thrombolysis devices are popular adjunct to percutaneous mechanical thrombectomy devices which uses x-ray imaging to guide medical device or medication to the site of blood clots and dissolve it.
Hence, growing patient inclination towards adopting minimally invasive procedures for the treatment of pulmonary embolism is propelling the demand for such venous thromboembolism management devices, driving the growth in the segment.
“Growing Risk of Blood Clots to Create Tailwind for Deep Venous Thrombosis Treatment”
As per FMI, the deep venous thrombosis segment is estimated to lead the global venous thromboembolism treatment market in terms of disease indication. It is expected to account for nearly 68.4% of the total sales in 2022.
Increasing risk of blood clots, causing deep venous thrombosis, due to growing cases of cancer, pregnancy, and cardiovascular diseases, especially across developing economies such as China, India, Australia, and others is propelling the demand in the deep venous thrombosis segment.
“Presence of Favorable Reimbursement Policies to Augment the Sales of Thromboembolism Treatment”
In terms of end user, the global venous thromboembolism treatment market is segmented into hospital, catheterization laboratories, and ambulatory surgical centers. FMI states that the hospital segment is projected to register robust growth in the market during the forecast period.
Increasing patient preference for visiting hospitals for the treatment of pulmonary embolism and deep venous thrombosis, owing to the presence of advanced medical infrastructure and favorable reimbursement policies is favoring the growth in the segment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key players in the global venous thromboembolism treatment market are investing in research and development activities for launching novel devices and therapeutics. Some of the other companies are aiming at receiving product approvals for their new products to gain competitive edge. For instance,
In June 2021, Janssen Pharmaceuticals, Inc, a Belgium-based pharmaceutical company, announced receiving Food and Drug Administration (FDA) approval for its new products XARELTO® (rivaroxaban) for the treatment of two indications - deep venous thrombosis and pulmonary embolism. This will assist the company to strengthen its footprint in the market.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2029 |
Historical Data Available for | 2014 to 2021 |
Market Analysis | US$ Billion for Value |
Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa |
Key Countries Covered | USA, Canada, Germany, UK, France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa |
Key Segments Covered | Product, Disease Indication, End User, and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
By Product:
By Disease Indication:
By End User:
By Region:
1. Executive Summary 1.1. Global Market Outlook 1.2. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation & Development Trends 4. Key Success Factors 4.1. Regulatory Scenario 4.2. Reimbursement Landscape 5. Global Venous Thromboembolism Treatment Market - Pricing Analysis 5.1. Regional Pricing Analysis By Product Type 5.2. Pricing Break-up 5.2.1. Manufacturer Level Pricing 5.2.2. Distributor Level Pricing 5.3. Global Average Pricing Analysis Benchmark 6. Global Venous Thromboembolism Treatment Market Demand (Value US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029 6.1. Historical Market Value (US$ Mn) Analysis, 2014-2021 6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Market Background 7.1. Macro-Economic Factors 7.1.1. Global GDP Growth Outlook 7.1.2. Global Healthcare Expenditure Outlook 7.2. Forecast Factors - Relevance & Impact 7.2.1. High prevalence of Venous Thromboembolism 7.2.2. Increasing demand for device treatment over drugs 7.2.3. Technological advancements in Venous Thromboembolism 7.2.4. Reimbursement 7.3. Value Chain 7.4. Market Dynamics 7.4.1. Drivers 7.4.2. Restraints 7.4.3. Opportunity Analysis 8. Global Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Product Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2014 - 2021 8.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Product Type, 2021 - 2021 8.3.1. Non-Segmented Pneumatic Compression Pumps 8.3.2. Segmented Pneumatic Compression Pumps without Gradient 8.3.3. Segmented Pneumatic Compression Pumps with Calibrated Gradient 8.3.4. Upper Pneumatic Compression Sleeves 8.3.5. Lower Pneumatic Compression Sleeves 8.3.6. Permanent Inferior Vena Cava Filters 8.3.7. Retrievable Inferior Vena Cava Filters 8.3.8. Embolectomy Balloon Catheters 8.3.9. Percutaneous Thrombectomy Devices 8.3.10. Catheter-Directed Thrombolysis (CDT) Devices 8.4. Market Attractiveness Analysis By Product Type 9. Global Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Disease Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Disease Type, 2014 - 2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2021 - 2021 9.3.1. Deep Venous Thrombosis 9.3.2. Pulmonary Embolism 9.4. Market Attractiveness Analysis By Disease Type 10. Global Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by End User 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 - 2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021 - 2021 10.3.1. Hospitals 10.3.2. Ambulatory Surgical Centers 10.3.3. Independent Catheterization Laboratories 10.4. Market Attractiveness Analysis By End User 11. Global Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2021 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021 - 2021 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. South Asia 11.3.5. East Asia 11.3.6. Oceania 11.3.7. Middle East & Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021 12.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029 12.4.1. By Country 12.4.1.1. U.S. 12.4.1.2. Canada 12.4.2. By Product Type 12.4.3. By Disease Type 12.4.4. By End User 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Product Type 12.5.3. By Disease Type 12.5.4. By End User 12.6. Market Trends 12.7. Key Market Participants - Intensity Mapping 12.8. Drivers and Restraints - Impact Analysis 13. Latin America Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021 13.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Product Type 13.4.3. By Disease Type 13.4.4. By End User 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product Type 13.5.3. By Disease Type 13.5.4. By End User 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 14. Europe Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021 14.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. Italy 14.4.1.3. France 14.4.1.4. U.K. 14.4.1.5. Spain 14.4.1.6. Russia 14.4.1.7. BENELUX 14.4.1.8. Rest of Europe 14.4.2. By Product Type 14.4.3. By Disease Type 14.4.4. By End User 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product Type 14.5.3. By Disease Type 14.5.4. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. South Asia Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021 15.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029 15.4.1. By Country 15.4.1.1. India 15.4.1.2. Thailand 15.4.1.3. Indonesia 15.4.1.4. Malaysia 15.4.1.5. Rest of South Asia 15.4.2. By Product Type 15.4.3. By Disease Type 15.4.4. By End User 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product Type 15.5.3. By Disease Type 15.5.4. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. East Asia Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021 16.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029 16.4.1. By Country 16.4.1.1. China 16.4.1.2. Japan 16.4.1.3. South Korea 16.4.2. By Product Type 16.4.3. By Disease Type 16.4.4. By End User 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product Type 16.5.3. By Disease Type 16.5.4. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. Oceania Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021 17.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029 17.4.1. By Country 17.4.1.1. Australia 17.4.1.2. New Zealand 17.4.2. By Product Type 17.4.3. By Disease Type 17.4.4. By End User 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Product Type 17.5.3. By Disease Type 17.5.4. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. Middle East and Africa Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Mn) & Volume Trend Analysis By Market Taxonomy, 2014 - 2021 18.4. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2022 - 2029 18.4.1. By Country 18.4.1.1. GCC Countries 18.4.1.2. South Africa 18.4.1.3. Turkey 18.4.1.4. Northern Africa 18.4.1.5. Rest of Middle East and Africa 18.4.2. By Product Type 18.4.3. By Disease Type 18.4.4. By End User 18.5.Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Product Type 18.5.3. By Disease Type 18.5.4. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Emerging Countries Venous Thromboembolism Treatment Market Analysis 2014-2021 and Forecast 2022-2029 19.1. Introduction 19.1.1. Market Value Proportion Analysis, By Key Countries 19.1.2. Global Vs. Country Growth Comparison 19.2. China Venous Thromboembolism Treatment Market Analysis 19.2.1. Introduction 19.2.2. Pricing Analysis 19.2.3. PEST Analysis 19.2.4. Market Value Proportion Analysis by Market Taxonomy 19.2.5. Market Value (US$ Mn) & Volume Analysis and Forecast by Market Taxonomy 19.2.5.1. By Product Type 19.2.5.2. By Disease Type 19.2.5.3. By End User 19.2.6. China Venous Thromboembolism Treatment Market - Competition Landscape 19.3. India Venous Thromboembolism Treatment Market Analysis 19.3.1. Introduction 19.3.2. Pricing Analysis 19.3.3. PEST Analysis 19.3.4. Market Value Proportion & Volume Analysis by Market Taxonomy 19.3.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 19.3.5.1. By Product Type 19.3.5.2. By Disease Type 19.3.5.3. By End User 19.3.6. India Venous Thromboembolism Treatment Market - Competition Landscape 19.4. South Korea Venous Thromboembolism Treatment Market Analysis 19.4.1. Introduction 19.4.2. Pricing Analysis 19.4.3. PEST Analysis 19.4.4. Market Value Proportion & Volume Analysis by Market Taxonomy 19.4.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 19.4.5.1. By Product Type 19.4.5.2. By Disease Type 19.4.5.3. By End User 19.4.6. South Korea Venous Thromboembolism Treatment Market - Competition Landscape 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies (Venous Thromboembolism Treatment) 20.2. Market Concentration 20.3. Market Share Analysis of Top Players 20.4. Market Presence Analysis 20.4.1. By Regional footprint of Players 20.4.2. Product foot print by Players 20.4.3. Channel Foot Print by Players 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Deep Dive 21.2.1. ArjoHuntleigh AB 21.2.1.1. Overview 21.2.1.2. Product Portfolio 21.2.1.3. Profitability by Market Segments (Product/Channel/Region) 21.2.1.4. Sales Footprint 21.2.1.5. Strategy Overview 21.2.1.5.1. Marketing Strategy 21.2.1.5.2. Product Strategy 21.2.1.5.3. Channel Strategy 21.2.2. DaeSung Maref Co., Ltd. 21.2.3. DJO Global 21.2.4. Argon Medical Devices 21.2.5. Lifetech Scientific 21.2.6. Cardinal Health 21.2.7. ALN Implants Chirurgicaux 21.2.8. Boston Scientific Corporation 21.2.9. Cook Medical 21.2.10. Volcano Corporation 21.2.11. Medtronic plc 21.2.12. Stryker Corporation 21.2.13. AngioDynamics Inc. 22. Assumptions and Acronyms Used 23. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 02 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 03 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 04 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 05 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region Table 06 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 07 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 08 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 09 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 10 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 11 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 12 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 13 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 14 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 15 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 16 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 17 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 18 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 19 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 20 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 21 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 22 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 23 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 24 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 25 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 26 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 27 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 28 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 29 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 30 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 31 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 32 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 33 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 34 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 35 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 36 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country Table 37 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 38 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 39 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 40 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 41 : Emerging Venous Thromboembolism Treatment Market Value Proportion Analysis 2014-2021 and Forecast 2022-2029, By Country Table 42 : Emerging and Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029 Table 43 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 44 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 45 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 46 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 47 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 48 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 49 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 50 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User Table 51 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 52 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Product Type Table 53 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Disease Indication Table 54 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Figure 01 : Global Venous Thromboembolism Treatment Market Revenue Share by Product Type, 2018A Figure 02 : Global Venous Thromboembolism Treatment Market Revenue Share by Disease Indication Type, 2018A Figure 03 : Global Venous Thromboembolism Treatment Market Revenue Share by End User, 2018A Figure 04 : Global Venous Thromboembolism Treatment Market Revenue Share by Region, 2018A Figure 05 : Global Venous Thromboembolism Treatment Market Historical Market Value (US$ Mn) Analysis, 2014–2021 Figure 06 : Global Venous Thromboembolism Treatment Current and Future Market Value (US$ Mn), 2022–2029 & Y-o-Y Growth Trend Analysis Figure 07 : Venous Thromboembolism Treatment Market Absolute $ Opportunity, 2021–2029 Figure 08 : Global Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type Figure 09 : Global Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication Figure 10 : Global Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User Figure 11 : Global Venous Thromboembolism Treatment Market Attractiveness Analysis, Region Figure 12 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 13 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 14 : U.S. Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014-2021 Figure 15 : U.S. Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2029 Figure 16 : Canada Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2014-2021 Figure 17 : Canada Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2029 Figure 18 : North America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type Figure 19 : North America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication Figure 20 : North America Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User Figure 21 : North America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country Figure 22 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 23 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2014–2021 Figure 24 : Brazil. Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 25 : Brazil Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2029 Figure 26 : Mexico Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2014–2021 Figure 27 : Mexico Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2029 Figure 28 : Rest of L.A Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 29 : Rest of L.A Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2029 Figure 30 : Latin America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type Figure 31 : Latin America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication Figure 32 : Latin America Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User Figure 33 : Latin America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country Figure 34 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 35 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 36 : Germany Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 37 : Germany Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 38 : France Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 39 : France Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 40 : U.K Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 41 : U.K Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 42 : Italy Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 43 : Italy Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 44 : Russia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 45 : Russia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 46 : Spain Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 47 : Spain Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 48 : BENELUX Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 49 : BENELUX Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 50 : Rest of Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 51 : Rest of Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 52 : Europe Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type Figure 53 : Europe Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication Figure 54 : Europe Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User Figure 55 : Europe Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country Figure 56 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 57 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 58 : Thailand Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 59 : Thailand Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 60 : Malaysia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 61 : Malaysia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 62 : Indonesia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 63 : Indonesia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 64 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 65 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 66 : Rest of South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 67 : Rest of South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2029 Figure 68 : South Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type Figure 69 : South Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication Figure 70 : South Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User Figure 71 : South Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country Figure 72: East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 73 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 74 : China. Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 75 : China. Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 76 : Japan Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 77 : Japan Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 78 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 79 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2029 Figure 80 : East Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type Figure 81 : East Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication Figure 82 : East Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User Figure 83 : East Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country Figure 84 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 85 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 86 : Australia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 87 : Australia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 88 : New Zealand Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 89 : New Zealand Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 90 : Oceania Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type Figure 91 : Oceania Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication Figure 92 : Oceania Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User Figure 93 : Oceania Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country Figure 94 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 95 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 96: GCC Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 97 : GCC Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 98 : Northern Africa Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 99 : Northern Africa Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 100 : South Africa Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 101 : South Africa Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 102 : Rest of MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 103 : Rest of MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022–2029 Figure 104 : MEA Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type Figure 105 : MEA Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication Figure 106 : MEA Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User Figure 107 : MEA Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country Figure 108 : Global Vs. Emerging Venous Thromboembolism Treatment Market Value (%) Analysis 2014-2021 and Forecast 2022-2029 Figure 109 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 110 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 111 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 112 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029 Figure 113 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2021 Figure 114 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2022–2029
Recommendations
Explore Healthcare Insights
View Reports